Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …
[HTML][HTML] Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies
C Wang, S Dai, X Zhao, Y Zhang, L Gong, K Fu… - Biomedicine & …, 2023 - Elsevier
Celastrol is a pentacyclic triterpenoid extracted from the traditional Chinese medicine
Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular …
Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular …
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
There are more than 70 distinct sarcomas, and this diversity complicates the development of
precision-based therapeutics for these cancers. Prospective comprehensive genomic …
precision-based therapeutics for these cancers. Prospective comprehensive genomic …
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
F Duffaud, O Mir, P Boudou-Rouquette… - The Lancet …, 2019 - thelancet.com
Background Regorafenib has proven activity in patients with pretreated gastrointestinal
stromal tumours and colorectal and hepatocellular carcinoma. We designed REGOBONE to …
stromal tumours and colorectal and hepatocellular carcinoma. We designed REGOBONE to …
Chondrosarcoma: a clinical review
A Gazendam, S Popovic, N Parasu… - Journal of Clinical …, 2023 - mdpi.com
Chondrosarcomas are a diverse group of malignant cartilaginous matrix-producing
neoplasms. Conventional chondrosarcomas are a continuum of disease based on the …
neoplasms. Conventional chondrosarcomas are a continuum of disease based on the …
[HTML][HTML] Nanomaterial-assisted theranosis of bone diseases
Bone-related diseases refer to a group of skeletal disorders that are characterized by bone
and cartilage destruction. Conventional approaches can regulate bone homeostasis to a …
and cartilage destruction. Conventional approaches can regulate bone homeostasis to a …
Personalized chordoma organoids for drug discovery studies
Chordomas are rare tumors of notochordal origin, most commonly arising in the sacrum or
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
skull base. Chordomas are considered insensitive to conventional chemotherapy, and their …
MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study
H Chen, X Zhang, X Wang, X Quan, Y Deng, M Lu… - European …, 2021 - Springer
Objective To develop and validate a radiomics signature based on magnetic resonance
imaging (MRI) from multicenter datasets for preoperative prediction of pathologic response …
imaging (MRI) from multicenter datasets for preoperative prediction of pathologic response …
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network …
B Zhang, Y Zhang, R Li, J Li, X Lu, Y Zhang - Journal of Orthopaedic …, 2020 - Springer
Background Osteosarcoma, a primary malignant bone tumor derived from mesenchymal
tissue, is the most common type of pleomorphic tumor that occurs in children and …
tissue, is the most common type of pleomorphic tumor that occurs in children and …
[HTML][HTML] Ewing sarcoma
S Durer, DP Gasalberti, H Shaikh - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Objectives: Identify early manifestations of Ewing sarcoma, distinguishing them from
common bone pathologies in adolescents. Differentiate between localized and metastatic …
common bone pathologies in adolescents. Differentiate between localized and metastatic …